The Company's 2021 consolidated Financial Statements
Statements have been approved by the Board of Directors
Date of events
2022/03/29
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/29
2.Date of approval by the audit committee:NA
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,550,382
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):646,192
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):68,717
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):56,041
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):36,046
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):28,877
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.30
11.Total assets end of the period (thousand NTD):3,280,649
12.Total liabilities end of the period
(thousand NTD):1,937,190
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,200,961
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Tex Year Industries Inc. published this content on 30 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2022 10:14:04 UTC.
TEX YEAR INDUSTRIES INC. is a Taiwan-based company mainly engaged in the processing, manufacture and trading of adhesive products. The Companyâs principal products include hot melt adhesives, pressure sensitive adhesives, instant adhesives, ultraviolet rays (UV) adhesives and paints, packaging materials for solar cell modules, electronic specialty chemicals, as well as medical steam autoclaves and medical anti-infection devices. The Company is also involved in the design, assembly, maintenance and trading of automation equipment, as well as the provision of related technology transfer and after-sales services. The Company mainly operates through three business segments: Taiwan chemical engineering segment, the Mainland China business segment and others segment. The Company mainly operates its businesses in Asia, the Americas and Europe.